CAJ | 학술논문

目的：观察院内制剂荣筋片治疗肾虚血瘀型原发性骨质疏松症的临床疗效。方法：将61例肾虚血瘀型原发性骨质疏松症患者随机分为2组。治疗组31例，服用荣筋片、罗盖全和钙尔奇D；对照组30例，服用罗盖全和钙尔奇D，2组均以4周为1个疗程，6个疗程后统计疗效。结果：总有效率治疗组为93.5％，对照组为73.3％，治疗组优于对照组，差异有统计学意义（ P＜0.05）。结论：荣筋片治疗肾虚血瘀型原发性骨质疏松症具有一定的临床疗效。
목적：관찰원내제제영근편치료신허혈어형원발성골질소송증적림상료효。방법：장61례신허혈어형원발성골질소송증환자수궤분위2조。치료조31례，복용영근편、라개전화개이기D；대조조30례，복용라개전화개이기D，2조균이4주위1개료정，6개료정후통계료효。결과：총유효솔치료조위93.5％，대조조위73.3％，치료조우우대조조，차이유통계학의의（ P＜0.05）。결론：영근편치료신허혈어형원발성골질소송증구유일정적림상료효。
Objective:To observe the clinical efficacy of Rongjin tablets in treating the kidney deficiency and blood stasis type of primary osteoporosis .Methods:Sixty one patients of the kidney deficiency and blood stasis type of primary osteoporosis were randomly divided into two groups,31cases in the treatment group treated with oral administration of Rongjin tablets , calcitriol soft gelatin capsules and Vi-tamin D Calcium Chewable Tablets and 30 cases in the control group given oral administration of calcitriol soft gelatin capsules and Vita -min D Calcium Chewable Tablets .4 weeks was a course of treatment and the clinical curative effect was observed after 6 courses of treat-ment.Results:The total effective rate in the treatment group was 93.5%,while that in the control group was 73.3%; the treatment group showed better efficacy than the control group , and the difference was significant (P<0.05).Conclusion:Rongjin tablets can a-chieve significant effect in treating the kidney deficiency and blood stasis type of primary osteoporosis .